Lung Health Declines in Step With Motor Loss in Types 2 and 3, Study Finds
SMA News Today’s multimedia associate, Price Wooldridge, discusses how lung health declines in step with motor loss in Spinal Muscular Atrophy (SMA) Types 2 and 3. Are you interested in learning more...
26 Nov 20205min
Reflecting On The Insanity of 2020 and The People Who Got Us Through This Year
Forums Director Kevin Schaefer reflects on the insanity of 2020, and talks about the people who got him through this year. To learn more about spinal muscular atrophy, visit our website at http://ww...
25 Nov 20205min
Spinraza’s Benefits Mild, Transient in Infant With Severe Type 0 SMA
SMA News Today’s multimedia associate, Price Wooldridge, discusses the mild, transient benefits of Spinraza treatment in an infant with severe, Type 0, Spinal Muscular Atrophy (SMA). Are you interest...
23 Nov 20205min
Molecule Similar to Evrysdi But Possibly Safe at Higher Doses Identified
SMA News Today’s multimedia associate, Price Wooldridge, discusses a molecule similar to Evrysdi, is possibly safer at higher doses has been identified. Are you interested in learning more about spin...
20 Nov 20207min
How An Urology Appointment Turned Into A Fiasco & Typing Strategies, Vitamin D and Friendsgiving
Forums Director Kevin Schaefer talks about how a recent urology appointment turned into a bit of a fiasco. He describes this as an “SMA kind of day.” Also, SMA News Today not only brings you the late...
18 Nov 20206min
#70 - Discussing the JACO Robotic Arm with Ron Borgschulte
In episode 70, host Kevin Schaefer and Michael Morale talk with entrepreneur Ron Borgschulte. Ron is the owner of Partners in Medicine, a company that works with Kinova Robotics to distribute assistiv...
17 Nov 202034min
Muscle MRI Captures Spinraza’s Effects on Tissue Fibers in Type 3 Brothers
SMA News Today’s multimedia associate, Price Wooldridge, discusses how a muscle MRI captures Spinraza’s effects on tissue fibers in two brothers with Type 3 Spinal Muscular Atrophy (SMA). DeAnn Runge...
16 Nov 20208min
NICE Reviews UK Spinraza Reimbursement for SMA Type 3 Patients Unable to Walk
SMA News Today’s multimedia associate, Price Wooldridge, discusses England’s National Institute for Health and Care Excellence (NICE) review of reimbursement for SMA Type 3 patients who are unable to ...
13 Nov 20204min
